Jens Juul Holst

Jens Juul Holst

Professor


  1. Published
  2. Published

    Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus. / Aaboe, K; Knop, F K; Vilsbøll, T; Deacon, C F; Holst, Jens Juul; Madsbad, S; Krarup, Troels Magelund.

    In: Diabetes, Obesity and Metabolism, Vol. 12, No. 4, 01.04.2010, p. 323-33.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published
  4. Published

    Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. / Holst, J J; Orskov, C; Nielsen, O V; Schwartz, T W.

    In: F E B S Letters, Vol. 211, No. 2, 1987, p. 169-74.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. / Wettergren, A.; Schjoldager, B.; Mortensen, P.E.; Myhre, J.; Christiansen, J.; Holst, Jens Juul.

    In: Digestive Diseases and Sciences, No. Vol. 38, no. 4, 1993, p. 665-673.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB. / Engelbrechtsen, Line; Lundgren, J; Wewer Albrechtsen, Nicolai Jacob; Mahendran, Yuvaraj ; Iepsen, Eva Pers Winning; Finocchietto, P.; Jonsson, Anna Elisabet ; Madsbad, Sten; Holst, Jens Juul; Vestergaard, Henrik; Hansen, T.; Torekov, Signe Sørensen.

    In: Obesity Science & Practice, Vol. 3, No. 4, 2017, p. 425-433.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. / Iepsen, E W; Lundgren, J; Dirksen, C; Jensen, J-Eb; Pedersen, O; Hansen, T; Madsbad, S; Holst, J J; Torekov, S S.

    In: International journal of obesity (2005), Vol. 39, No. 5, 2015, p. 834-41.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Treatment with GLP-1 Receptor Agonists. / Madsbad, Sten; Holst, Jens J.

    Diabetes: Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. ed. / E Bonora; R DeFronzo. Springer, 2018. (Endocrinology).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  9. Published

    Treatment of type 2 diabetes with glucagonlike peptide 1. / Holst, J.J.

    In: Current Opinion in Endocrin. and Diabetes, No. 5, 1998, p. 108-115.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists. / Hansen, K B; Knop, F K; Holst, Jens Juul; Vilsbøll, T.

    In: International Journal of Clinical Practice, Vol. 63, No. 8, 2009, p. 1154-60.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...145 Next

ID: 4207